Phase I Trial of Rituximab, Cladribine and Temsirolimus (RCT) for Initial Therapy of Mantle Cell Lymphoma
- Citation:
- ASH Annual Meeting Abstracts vol 120 (21) -3661
- Meeting Instance:
- ASH 2012
- Year:
- 2012
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2420
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- D. J. Inwards P. Fishkin B. R. Laplant M. T. Drake P. Kurtin D. Nikcevich D. Wender B. Lair T. E. Witzig
- Networks:
- Study
- NCCTG-N078D
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords: